Iatrogenic Cushing’s Syndrome with Secondary Adrenal Suppression Misdiagnosed as Protease Inhibitor-Induced Lipodystrophy in an HIV Positive Patient: Case Report
Journal Title: Haematology International Journal - Year 2017, Vol 1, Issue 2
Abstract
1.1. Background: Ritonavir is a commonly prescribed protease inhibitor (PI) which is used in low doses to boost levels of other protease inhibitors pharmacokinetically. It is a potent inhibitor of hepatic cytochrome P450 3A4 (CYP3A4) isoenzyme and reduces the metabolism of systemic steroids leading to clinical Cushing's syndrome and secondary adrenal insufficiency. Despite occasional reports of Cushing's syndrome occurring with the use of injectable triamcinolone, even in the absence of CYP3A4 inhibition, it is unclear if caution should be exercised when considering local steroid injections in the setting of ritonavir therapy. We herein report the case of an iatrogenic steroid induced Cushing’s syndrome due to triamcinolone-ritonavir interaction misdiagnosed as PI induced lipodystrophy. 1.2. Case Presentation: We present the case of a 47-year-old HIV positive African male patient, who was switched from Tenofovir/ Lamivudine/ Efavirenz combination therapy to Abacavir/ Lamivudine/ Atazanavir/ Ritonavir due to virologic failure and had been on this new regimen for 1 year. He had been on over-the-counter intramuscular triamcinolone for 3 months, for knee pain and presented with a 2-month history of weight gain, swollen face and distended abdomen. Clinical examination revealed a moon face, dorsocervical hump, central obesity, fair skin, and pitting edema. He was initially thought to have PI induced lipodystrophy but after thorough examination and laboratory investigations, a diagnosis of iatrogenic Cushing syndrome with adrenal suppression was made and he was managed with hydrocortisone replacement therapy with marked regression of symptoms thereafter. 1.3. Conclusion: Cushing’s syndrome should be considered as an important differential in HIV positive patients on PI who develop abnormal fat deposition, especially in the context of steroid use. A high index of suspicion is required for early diagnosis and management. Whenever possible, the use of glucocorticoid therapy through any route should be avoided in patients on ritonavir-boosted protease inhibitor therapy.
Authors and Affiliations
Derrick Tembi Efie
Keywords
Related Articles
- EP ID EP291042
- DOI -
- Views 99
- Downloads 0
Environmental Factors as Determinants of Severity of SCD in Nigeria
Sickle cell anaemia (SCA) is a chronic blood disorder characterized by red blood cells that assume an abnormal sickle shape when deoxygenated and may block different areas of the microcirculation causing ischaemia in var...
Differential Correlation between Foetal Haemoglobin and Full Blood Count Based on Inherited Haemoglobin Type; A Cross-Sectional Study in Cape Coast, Ghana
1.1. Background: Foetal haemoglobin (Hb F) has been shown to modulate the severity of sickle cell anaemia (SCA). However, there is scarcity of data on the impact of Hb F levels in other inherited haemoglobin variants. Th...
A Unique Case of Primary Hepatic CD30-Positive, CD15-Negative Classical Hodgkin’s Lymphoma Presenting as Fever of Unknown Origin and Acute Hepatic Failure
Hodgkin’s lymphoma is a B-cell lymphoproliferative neoplasm that commonly presents with lymphadenopathy and constitutional symptoms. Primary Hodgkin’s lymphoma of the liver without extrahepatic lymphadenopathy is rare, r...
Cost-Effectiveness of Idelalisib-Rituximab for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
1.1. Background: A significant survival prolongation was recently reported by adding idelalisib to rituximab (IR) compared with rituximab (R) in the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL). No...
A Survey of Clinicians Practice Patterns in Anticoagulation Therapy & Prophylaxis in Nigeria
Introduction: Therapeutic and prophylactic anticoagulation is under-prescribed in Nigeria, Dismal practice patterns of anticoagulation, lack of hospital-based anticoagulation policy may be contributory Objective: The aim...